Breaking boundaries with shared language.

GET CONNECTED
generalneuro.com

General Neuro Inc

Company details

General Neuro (NeuroLingo) is building a closed-loop neurostimulation system paired with an AI-first, gamified language-learning app to accelerate second-language acquisition by boosting brain plasticity with personalized electrical stimulation. The system adapts stimulation parameters in real time based on measured learning performance to improve consistency across individuals.

The company launched NeuroLingo Model 1 in July 2025 ($150, $30 COGM) to drive consumer data collection and product refinement, and plans NeuroLingo Pro ($500 + $10/month) focused on institutional customers such as military, universities, and language institutes.

Pre-SeedHAX Seed 2025

Get In Touch with General Neuro Inc

Please tell us a little bit about yourself and why you'd like to get connected. General Neuro Inc + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More